## **Core Concept**
Hematoxylin bodies are a histopathological feature observed in certain autoimmune diseases. They are primarily composed of nuclear material that has been extruded from damaged cells and stained with hematoxylin, appearing as purple or blue masses. This phenomenon is often associated with **Systemic Lupus Erythematosus (SLE)**.

## **Why the Correct Answer is Right**
The correct answer, **D. Systemic Lupus Erythematosus (SLE)**, is associated with hematoxylin bodies because in SLE, there is an increased rate of apoptosis leading to the formation of these bodies. The process involves the condensation and fragmentation of nuclei, leading to the release of nuclear material into the tissue. This material can then stain densely with hematoxylin, forming characteristic hematoxylin bodies. This feature is a hallmark of SLE and is often used in the histopathological diagnosis of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain infections can lead to cellular damage and necrosis, they are not characteristically associated with the formation of hematoxylin bodies.
- **Option B:** Rheumatoid Arthritis (RA) is an autoimmune disease primarily affecting joints. Although it involves immune complex deposition and inflammation, it is not typically associated with hematoxylin bodies.
- **Option C:** Sjögren's syndrome is another autoimmune disease that primarily affects exocrine glands, particularly the salivary and lacrimal glands. Like RA, it involves immune complex deposition but is not characteristically associated with hematoxylin bodies.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that hematoxylin bodies are not only a diagnostic feature but also indicative of the disease's activity and severity in SLE. Their presence supports the diagnosis of SLE when considered alongside other clinical and serological criteria. It's also worth noting that while they are highly suggestive of SLE, they are not pathognomonic and can be seen in other conditions with high levels of apoptosis.

## **Correct Answer:** D. Systemic Lupus Erythematosus (SLE).